MRNA Mar 2025 70.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:40AM EDT. Market open.
| Previous Close | 43.25 |
| Open | N/A |
| Bid | 96.00 |
| Ask | 104.95 |
| Strike | 70.00 |
| Expire Date | 2025-03-21 |
| Day's Range | 43.25 - 43.25 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 3 |
ZacksModerna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Simply Wall St.Moderna (NASDAQ:MRNA) shareholders are still up 857% over 5 years despite pulling back 6.1% in the past week
Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...
ACCESSWIREModerna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
mRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older Higher efficacy was observed in mRNA-1283 compared ...
© 2024 Yahoo. All rights reserved.